High blood pressure is a modifiable risk factor for heart disease and contributes about $131 billion annually to the cost of healthcare services, according to the Centers for Disease Control and Prevention. In a study from Yale University, scientists found a potential target for the development of high blood pressure drugs.
Comments are closed.